GSK-3 (GlaxoSmithKline) Drug Overview & Product Profiles, 2018 - ResearchAndMarkets.com

DUBLIN--()--The "GSK-3" report has been added to ResearchAndMarkets.com's offering.

Drug Overview

GSK-3 is a 10-valent pneumococcal polysaccharide and non-typeable Haemophilus influenzae protein D conjugate vaccine, which also includes the conserved, unconjugated pneumococcal proteins dPly and PhtD. dPly is a thiol-dependent toxin, while PhtD is a protein which is exposed on the surface of intact bacteria, and vaccines based on these proteins have the potential to provide broader protection against pneumococcal disease.

Research Outlook

GSK-3's (10-valent recombinant-conjugate pneumococcal vaccine; GlaxoSmithKline) novel vaccine approach and potential for broader coverage will make it a strong contender on the market, but it will face significant competition from Prevnar 13 (13-valent

pneumococcal conjugate vaccine; Pfizer), as well as pipeline vaccines V114 (15-valent pneumococcal conjugate vaccine; Merck & Co) and PF-06482077 (20-valent pneumococcal conjugate vaccine; Pfizer), which also aim to provide broader protection.

Key Topics Covered

  1. Drug Overview
  2. Product Profiles
  3. GSK-3 : Pneumococcal vaccines

List of Tables

Table 1: GSK-3 drug profile

Table 2: Trials of GSK-3 for pneumococcal vaccination

Table 3: GSK-3 for pneumococcal vaccination - SWOT analysis

For more information about this report visit https://www.researchandmarkets.com/r/dqv0xc

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines